Table 1 The clinical and laboratory characteristics of all participants
From: Soluble CD40 ligand and prolactin levels in migraine patients during interictal period
|  | Migraine subjects (n = 50) | Control subjects (n = 25) | p |
|---|---|---|---|
Age (years) | 38.0 ± 8.6 | 34.4 ± 7.8 | Ns |
Hypertension (%) | 9.3 | 9.0 | Ns |
Diabetes mellitus (%) | 4.4 | 0 | Ns |
Smoking (%) | 42.4 | 50 | Ns |
BMI (kg/m2) | 26.54 ± 5.52 | 23.98 ± 3.18 | <0.05 |
Systolic BP (mmHg) | 118.09 ± 17.4 | 123.63 ± 23.77 | Ns |
Diastolic BP (mmHg) | 77.44 ± 16.34 | 77.27 ± 11.03 | Ns |
Glucose (mg/dl) | 91.76 ± 10.76 | 93.85 ± 22.8 | Ns |
Cholesterol (mg/dl) | 189.88 ± 38.04 | 183.42 ± 40.28 | Ns |
Triglyceride (mg/dl) | 106.21 ± 44.54 | 102.85 ± 53.97 | Ns |
LDL (mg/dl) | 119.92 ± 32.38 | 111.68 ± 32.90 | Ns |
HDL (mg/dl) | 50.03 ± 12.52 | 49.29 ± 15.88 | Ns |
Platelet (/mm3) | 274361 ± 59207 | 263062 ± 60698 | Ns |
MPV (fL) | 9.53 ± 1.4 | 8.7 ± 0.92 | <0.05 |
Prolactin (ng/mL) | 11.34 ± 8.63 | 10.89 ± 5.0 | Ns |
hs-CRP (mg/L) | 4.28 ± 4.01 | 3.91 ± 3.89 | Ns |
sCD40L (ng/mL) | 11.92 ± 5.26 | 7.72 ± 3.6 | <0.001 |